Salgueiro Rodríguez M, Pérez Pombo S, Beiras García E
Med Clin (Barc). 1981 Feb 10;76(3):121-4.
The cardioselective betablocking agent metoprolol was used to treat 21 outpatients with essential arterial hypertension graded 1 and 2 of the OMS scale. The treatment was given orally for a mean duration of nine weeks at doses of 100 mg/day for two weeks and 200 mg/day for the remaining time. The treatment caused a significant reduction of systolic and diastolic arterial pressure (p less than 0.001), both in the erect and the lying down position. The heart rate was also significantly reduced both in the lying down (p less than 0.01) and the erect (p less than 0.05) positions. Metoprolol was shown to be effective and well tolerated as an antihypertensive agent; the treatment had to be interrupted in a single case because of dizziness, tiredness and dullness.
选用心脏选择性β受体阻滞剂美托洛尔治疗21例世界卫生组织(OMS)分级为Ⅰ级和Ⅱ级的原发性高血压门诊患者。口服给药,平均疗程9周,开始2周剂量为100毫克/天,其余时间剂量为200毫克/天。治疗使收缩压和舒张压显著降低(p<0.001),无论在直立位还是卧位。心率在卧位(p<0.01)和直立位(p<0.05)时也显著降低。结果表明,美托洛尔作为一种抗高血压药物有效且耐受性良好;仅1例因头晕、疲倦和嗜睡而中断治疗。